The manuscript from the laboratory of Soochul Park attempts to demonstrate a role for EphA receptor endocytosis in retinocollicular topographic map formation. The authors used BAC transgenesis to express in the superior colliculus a mutant form of EphA8 which is endocytosis defective (and perhaps signaling defective). These mice have 3-fold higher levels of EphA8 protein in anterior SC and present mapping defects: nasal axons expressing ephrinA5 were aberrantly shifted to the anterior SC, where the mutant EphA8 protein was enriched. Similar defects were observed in mice expressing dominant-negative Rac1, and opposite shifts in nasal axon mapping were observed in mice expressing wild-type EphA8. Since, in vitro, mutant EphA8 has dominantnegative effects on endocytosis of co-expressed wild-type EphAs, the authors conclude that this mechanism also underlies the in vivo mapping defects and propose that "endocytosis of the Ephephrin complex is a key mechanism by which axonal repulsion is generated for proper guidance and topographic mapping."
Overall this study is technically well done and provides convincing and concordant data. I also think that (lack of) endocytosis is likely to play a role in the observed mapping defects. But because of the overexpression approach, more than one interpretation seems possible. The authors do not discuss the (less interesting) possibility that the simple increase of endocytosis-defective EphA8 in anterior SC makes this region more adhesive for ingrowing ephrinA5-expressing RGC axons (blocking endocytosis has previously been shown to convert repulsion to adhesion in vitro). Consequently, these axons would form aberrant termination zones in the area where mutant EphA8 is enriched. Such an interpretation is supported by the ex vivo experiments in Fig.8 . This model would not allow the conclusion that Eph endocytosis is physiologically necessary for map formation. Eph ectodomain cleavage by metalloproteases (if that were the underlying mechanism for repulsion) would also be overridden by the overexpression approach. The overexpression of dnRac1 adds some support to the endocytosis idea, because Rac1 has previously been implicated in Eph endocytosis in vitro (although many other things are probably affected by this manipulation).
I could not detect any obvious technical flaws in this paper. I suggest that the authors modify the text according to the above suggestions and discuss the possible underlying mechanisms (dominantnegative effects on endocytosis of co-expressed wild-type EphAs versus mutant EphA8 having adhesive effects on nasal axons).
Referee #2 (Remarks to the Author):
The manuscript from Yoo and Kim et al. for the Soochul Park lab investigates the role of endocytosis of EphA receptors in the SC on the development of the retinocollicular map. The Park lab is interested in the function of the EphA8 receptor for a long time now, and this paper provides some interesting new data, not so much in this case on EphA8 in particular but on the function of EphAs as a whole in the SC. EphAs function here as ligands for ephrinAs expressed on retinal ganglion cell axons which signal by reverse signalling into retinal axons.
Essentially the key experiments are overexpression of an endocytosis-deficient EphA8 receptor in the SC and overexpression of a wt EphA8 receptor in the SC. With the idea to either flatten or steepen the existing EphA gradient. In both cases some changes in retinocollicular mapping are reported, in case of endocytosis-deficiency ectopic termination zones of nasal axons are formed in the anterior/medial part of the SC, and in case of overexpression nasal axons appear to be pushed more towards the posterior end of the SC. In addition the role of rac, TIAM and other molecules on endocytosis of EphA receptors is investigated in vitro and in vivo. This is indeed a very long paper with multiple data, and one might ask whether it would be better to take some data out leading to a more focussed paper.
I find the data on endocytosis of EphA receptors weak, and I think this aspect requires some more experiments. I would like to see double immunostainings showing internal and external EphA receptors at different time points, by successive antibody staining like shown in the paper from R. Klein's lab on endocytosis of EphB receptors. Dominant-negative effect: other EphA receptors including EphA4,5,6 and 7 are expressed at much higher levels than ephA8. I think it is not possible that the small amount of endocytosis-defective EphA8 inactivates the endocytosis of these other EphA receptors to an extend causing these effects, even if the endocytosis-deficient EphA8 receptor has a longer half life.
EphA8 is expressed early in the mesencephalon around E10, but at relevant stages of map formation, that is from around P0 to P6, it is basically not expressed in the SC according to data from Park et al 1997, and here only in a very tiny domain. The new in situ data of Figure 3 are of very poor quality, and better analyses have to be provided. The same is true for the protein stainings using ephrinA5-Fc and EphA8-Fc which are not of publishable quality. Compare here to the Feldheim Cell paper, Suppl. from 2009.
In vivo analysis of mutant mice should be carried out by analysing the litter of BAC heterozygous mice. What is the result here? Is there a phenotype for the heterozygous offspring?
With regard to the ephrinA5-GFP BAC mouse line, the authors do not describe the expression of GFP (ephrinA5 expressing cells) at earlier time points of map development. I would like to see an analysis of section from P1 and P3 mice to get an idea on the ratio between retina and SC cellsderived GFP/ephrinA5 expression in the SC.
Subsequently, the quantifications of map disturbance using ephrinA5 -GFP BAC mice are rather small and not convincing. The authors should show the change in targetting of nasal axons by DiI tracings in mice overexpressing EphA8 via a BAC that is a shift of medionasal axons more towards the caudal SC. Are here too ectopic termination zones formed?
Fig 8: it appears to me rather difficult to count the number of axons in this outgrowth assay. In the example of Fig. 8 a and b , also the explant is much closer to the cell clump, that is the reason for the increased ingrowth at least in this case might be simply because it is closer to the cell clump. If there is adhesion why do the axons then grow so much into the cell clump? Can the authors add a soluble ephrinA5-Fc to the medium to abolish the effect?
What is the cause for the great variation between the two transgenic BAC mice, if the genomic region is so large that position-dependent effects can be excluded, at least as the theory goes. It appears that there are indeed position-dependent effects.
I don't understand the model at all, it does not make any sense to me at all, e.g. why should in the wt situation a forward endocytosis ( fig. 12 ) leaving the p75 receptor in the axonal membrane result in a stronger repellent ephrinA signal? It does not make sense as for repulsion an ephrinA/p75 complex is necessary. In case of a block of endocytosis it would be expected that axons actually are glued to the anterior tectum because now the high-affinity interaction is not broken.
Other general point:
The Results section contains numerous interpretations of data. Ideally Results and Discussion are clearly separated.
Referee #3 (Remarks to the Author):
Overall, this is an elaborate and elegant study using multiple transgenic lines singly, in vitro, and in clever informative combinations to demonstrate a critical role for endocytosis of EphA receptors in the repellent activity through ephrin-A reverse signaling. Distinct axon labeling techniques (both beautifully accomplished and presented), distinct in vitro assays, and biochemical techniques are used in a logical and compelling manner to effectively demonstrate a role of EphA endocytosis in reverse signaling, as well as investigating the role of Rac in this process. In addition, multiple in vivo lines of evidence, again utilizing multiple transgenic lines, demonstrate the in vivo consequences of manipulating this system in retinocollicular topographic mapping. This manuscript will add a novel and unexpected mechanism to growing literature concerning topographic mapping, the role of Ephs/ephrins and specifically the role of reverse signaling, of which not a great deal is known. These compelling data are of broad interest and add an unexpected apparent mechanism crucial to repellent activity through reverse ephrin-A signaling. These data will be of substantial interest to the fields of axon guidance, topographic mapping, cell migration, synapse development, and plasticity. The only major shortcomings, in my view, is some confusion regarding labeling on some graphs, and a lack of a compelling discussion concerning the novelty and consequences of the proposed mechanism.
Specific comments generally following the order presented in the manuscript:
1. Figure 1 solidly establishes an endocytosis assay used throughout to significant effect. Some minor points are that Figs. 1B, 1D, and 1E are not appropriately referred to within the Results section. The major point that needs to be addressed concerns Fig 1B, the analysis of the endocytosis assay used throughout the manuscript (these comments apply to every similar graph presented in later figures). The two issues are: it is not made clear what is being measured, and the labeling on the graph is confusing. First, it is never clear what is being measured, presumably pixel intensity or similar, but the variance in the values throughout seem broad and not clearly associated with pixel intensity. A more complete description (controls, normalization, actual measurement procedure) in Experimental Procedures would be helpful as the only description I can find is on pg 37 " For each experiment, 30 -50 cells were analyzed using NIH ImageJ software." The second significant issue is easily correctable, yet important. The Y-axis of this graph, and others like it is labeled "Relative binding of ephrinA5-Fc". It is simply the use of the word 'Relative' that creates substantial confusion. The y-axis is not a relative measure, but, as far as I can tell a single measurement, it is the graph in its entirety that represents a relative view of binding. The label as is suggests that each bar is a relative value. As I understand the data, this is not the case. So, "Relative binding of ephrinA5-Fc" is more appropriate as a graph title than an axis label. Something like "Fluorescent intensity" or similar, if appropriate would be much clearer. Nonetheless, the photos in Fig 1A and my understanding of the data makes for a compelling case, so the conclusions drawn seem solid, though require substantial clarification.
2. A minor point regarding the biochemical data presented, for example in Fig. 1E , though applicable to every such Figure. It would improve clarity to label the constructs completely, for example, including -HA onto constructs that are EphA-HA. This allows for complete clarity without a need to refer to the Legend or text. Again, a minor point, but this would improve the overall presentation.
3. A minor point, but Fig 2B would be improved with a little more structural information, such as SC borders (as in Fig 4A) . Also, this panel seems severely whitewashed; a better photo would be more compelling. 7. In Fig 10E (bottom) , it is unclear if the axons have actually encountered the EphA8 transfected 293 cells. This particular 293 clump is much further away from the retinal explant than other examples. The quantification is solid, however, it is unclear what the criteria were for including a given explant in the data set. Given that the crucial measurement is axon invasion of the 293 clumps, it is clearly relevant that the axons have in fact extended at least to the border of the 293 cells. I would like to see a clarification or criteria that addresses this issue. I realize it is a demonstration of repulsion, but it is contact-mediated repulsion and the images do not show any axons close to the 293 clump (i.e. evidence of contact). The data are compelling, but this should be addressed. 8. A minor point, I do not find N for SC data.
9. In the Discussion (pgs 23, 26, 31, 33) the phrase "convert attractive signals to repulsive signals on RGC axons," is used. I don't think this is the proper terminology as the attractive signal has not been demonstrated sufficiently. The terminology along the lines of delineating a mechanism allowing for two surface bound molecules to promote repulsion, or something more similar to the terminology in the Introduction where 'adhesion' is used in place of attraction would be a better supported statement.
10. In the Discussion, pg 30: " "However, if the EphA extracellular domain is completely responsible for inducing the repellent activity on ephrin-As, we would expect that the appropriate nasal RGC axons would experience higher levels of repellent activity and that their termination domains would become posteriorly shifted toward the end of the SC."
This should be clarified to indicate that this prediction is true for the EphA8-E10 mouse, and not wild type mice. It is in context, but the context is lengthy and complex, thus some precision in language here would be useful.
11. The Discussion is appropriate, however, there are some important points I would like to see addressed, or addressed more thoroughly: a) In Fig 7 and Fig 11, the anterior shift in mapping in the SC are manifested (much) more medially than laterally. I am not clear as to why this would be so. b) Previous reports demonstrate a repulsive role for EphAs in vitro (e.g. Rashid et al., Lim et al.) where EphA endocytosis is impossible. Some explanation or comment on this would be informative. c) On pg 32 "we propose that the removal and trans-endocytosis of ephrin-As from nasal RGC axons may strengthen the activation of their co-receptors such as p75NTR" This comment certainly matches the data appropriately, but some elaboration is useful. Does endocytosis trigger ephrin-A cleavage from the axon membrane? Is there a retrograde signal if cleavage does occur? d) Similar to point 11c, a discussion about the uniqueness of these results is appropriate. Fundamentally, Ephrin-As on RGC axons are endocytosed into EphA expressing SC cells, and if they are not the axon behaves aberrantly. But if the ephrin-A is still cleaved from the axon, how does this result in a reduced repellent response? Are ephrin-As cleaved if endocytosis is affected? Schematic model suggests no, which makes everything work, but can this be shown? In effect, the primary question "Why does it matter to RGC axons what happens to ephrin-As after they are released from the axon membrane surface?" is a mystery and deserves comment.
12. An additional experiment that could provide a more complete mechanism would be the demonstration of the cleavage state of ephrin-As on axons upon encountering EphA expressing cells capable of wild type or aberrant endocytosis. Response to reviewer #1 This reviewer suggested that we need to discuss the adhesive effects of mutant EphA8 on nasal axons because we used the overexpression approach to observe its effect both in vitro and in vivo. It is possible that the EphA8-E10 mutant does not have dominant negative effects in vivo. The defective internalization of this mutant may be simply due to its unique structural defect, and the subsequent enhanced adhesion between nasal RGC axons and anterior superior colliculus (SC) cells may override the repellent signaling by the ephrinA-p75NTR complex or the metalloproteasemediated Eph ectodomain cleavage. This may be one reason why we observed aberrant termination zones (TZs) where the EphA8-E10 mutant is enriched. Therefore, we cannot rule out the adhesive effects of the EphA8-E10 mutant on nasal axons (page 28, lines 6-8).
However, several observations support our hypothesis that the EphA8-E10 mutant is likely to act as a dominant negative mutant against endocytosis of EphA receptors expressed in the anterior SC. First, the EphA8-E10 mutant can form a complex with the EphA4 receptor despite the fact that it lacks the peptide motif critical for endocytosis. This EphA receptor heteromerization with EphA8-E10 impairs efficient interactions with Rac-GEF and reduces Rac activity, thereby blocking efficient endocytosis in 293 cells (page 24, lines 1-9). Second, in transgenic mice expressing the endocytosis-defective EphA8-E10 receptor, primary SC cells with EphA receptors display a significant reduction in Rac activity and subsequent endocytotic behavior (page 25, lines 5-10). Third, in a co-culture experiment, nasal RGC axons show a strong preference for cell aggregates expressing both EphA8-E10 and wild-type EphA4 but a significant avoidance of cell aggregates expressing both wild-type EphA8 and EphA4 (see 'referee only' figure 3 [ed: data not included in this Peer Review Process File]). Based on these findings, we propose that mutant EphA8 has dominant-negative effects on endocytosis of co-expressed wild-type EphAs in the anterior SC.
Response to reviewer #2 Point 1.
The reviewer suggested that we remove some data to create a more focused manuscript. We agree with the reviewer so that we decided to transfer four figures (Figs. 2, 3, 9 and 12 in the first round of review) to the supplementary materials (see supplementary figures 1-4) . We feel all of these data need to be shown in the revised manuscript because other reviewers questioned whether the overexpression approach of the EphA8-E10 mutant may cause the observed phenotype due to a reason other than the inability to undergo endocytosis. We needed to provide more direct data to support our hypothesis, and in particular, the overexpression of dnRac1 both in vitro and in vivo was added to the manuscript to strengthen the endocytosis idea because Rac1 has previously been implicated in Eph endocytosis in vitro.
Point 2.
The reviewer suggested that we need to perform more endocytosis experiments such as double immunostaining at different time points. As shown in 'referee only' figure 1, [ed: data not included in this Peer Review Process File] either 293 cells or primary SC cells were treated with ephrinA5-Fc at 37°C for the indicated times. After ligand stimulation, cells were fixed in the absence of detergents and immunolabeled for ephrinA5-Fc on the cell surface using FITC-labeled Fc antibodies. Then, cells were permeabilized and stained for the internalized ephrinA5-Fc with Texas Red-labeled Fc antibodies. As a control, cells were also stimulated with ephrinA5-Fc at 4°C for 30 min to block internalization. In these control cells, both red and green fluorescent clusters were strongly co-localized, demonstrating that surface-bound ephrinA5-Fc is not internalized into cells under this condition (see the first panels). Internalized ephrinA5-Fc was measured based on the total intensity of the red fluorescent clusters that are found inside the cells but not co-localized with green fluorescent cell surface labeling. It was evident that the level of the internalized ephrinA5-Fc gradually increased, showing good correlation with the ligand stimulation time.
Point 3.
The reviewer claimed that EphA8 is expressed at a much lower level than other EphA members in the SC and that such a low level of EphA8 would not be expected to have a dominantnegative effect. We do not agree with the reviewer's point that EphA8 is expressed at a much lower level than other EphAs. It is impossible to compare expression levels of different EphA genes in the SC with different antibodies or in situ hybridization probes because each probe derived from different genes has different efficiency, affinity, stability, etc. Our in situ RNA hybridization and Western blot analysis clearly showed that EphA8 is significantly expressed in the anterior SC (see supplementary Fig. 1E ; supplementary Fig. 2A ). More importantly, using transgenic mice expressing the endocytosis-defective EphA8-E10 receptor, we demonstrated that primary SC cells with EphA receptors display a significant reduction in Rac activity (Fig. 8A ) and subsequent endocytotic behavior (Fig. 3G-H) .
Point 4.
Park et al. (1997; EMBO J, 16, 3106-3114) wrote: "At birth, LacZ expression (represents the developmental expression of EphA8) localized to a subpopulation of superior colliculus cells. X-gal staining of this region decreased after birth, appearing very weak by postnatal day (P) 5 and no longer detectable after P10." In that paper, the authors used a gene targeting approach with a mutant allele encoding a chimeric transmembrane protein of 1205 amino acids with a short EphA8 extracellular domain, the TrkA transmembrane domain, and a cytoplasmic region consisting of a functional b-galactosidase protein. According to our experience with these mice for more than a decade, it appears that the chimeric EphA8-TrkA-LacZ fusion protein has much weaker b-galactosidase activity and does not faithfully recapitulate the precise level of EphA8 gene expression during brain development. Our in situ RNA hybridization revealed that EphA8 is significantly expressed in the SC from P0 to P6, the critical period for retinocollicular map formation (see supplementary Fig. 2A ).
Point 5.
As the reviewer suggested, we have tried to improve the quality of the in situ data, and the best results are now shown in supplementary Figure 2 . Some of results were used in the figure we submitted to the EMBO Journal for the first round of review. We used a 10-mm sagittal section for in situ RNA hybridization with a digoxigenin-labeled antisense RNA probe. After color development, some of the sections were torn because they were processed at a high temperature (60°C). This phenomenon became more serious in sections close to the midline of the SC, which shows high expression of EphA receptors (see supplementary Fig. 2A) .
Feldheim et al, (Cell, 2009 ) used Eph-AP or ephrin-AP to stain ephrin-A and EphA, which is a more convenient and reliable detection method due to its use of alkaline phosphatase activity. However, in our Fc staining, we used ephrinA5-Fc and EphA8-Fc to stain the region where EphA and ephrin-A are expressed, respectively. These techniques use a fluorescence-conjugated secondary antibody, require more processing for staining, and thus, are not technically comparable to the method described in Feldheim et al, (Cell, 2009 ). We did our best to improve the staining procedure with the Fc-fusion probe, and we hope that the reviewer is satisfied with our new staining presented in supplementary Fig. 2B .
Point 6.
Throughout the entire manuscript, we performed in vivo analysis of mutant mice using littermates. In other words, the wild-type mice described in the manuscript are offspring born along with other transgenic mutant mice from the same mother but that do not carry the transgene. In addition, we used hemizygous offspring for the in vivo analysis of mutant mice. For example, the mice expressing both EphA8-E10 and GFP were generated by crossing a male that was hemizygous for EphA8-E10 with a female that was hemizygous for ephrinA5-GFP.
Point 7.
As the reviewer suggested, we prepared the retina and SC sections from ephrinA5-GFP BAC mice at P1 and P3, respectively (see 'referee only' figure 2 [ed: data not included in this Peer Review Process File]). In each experiment, the GFP image was obtained 1 day after the right eye was enucleated. At P1, GFP-labeled cells were predominantly observed in the nasal retina ('referee only' figure 2, first panel [ed: data not included in this Peer Review Process File]). It appears that axonal degeneration in the SC was not complete at this stage because some axonal projections were still detectable in the left SC (panel a). In the right SC, axonal projections had many interstitial branches, indicating that the retinotopic map was not mature (panels b and c). Similar results were observed in P3 mice, except that enucleation-induced axonal degeneration was almost complete in the left SC (see 'referee only' figure 2, panel a [ed: data not included in this Peer Review Process File]). Because the EGFP signal remained almost the same in the posterior region of both the right and left SC at P3, this signal likely reflects the endogenous expression of ephrin-A5 in the posterior SC. However, this RGC axon-independent GFP signal became very weak at P10 as shown in Fig.  3C .
Point 8.
Before we used ephrinA5-GFP mice to investigate the quantification of map disturbance, we performed a focal DiI injection and tracing to investigate whether the targeting of the nasal RGC axons was altered in mice overexpressing wild-type EphA8. As shown in 'referee only' Figure 4 [ed: data not included in this Peer Review Process File], we injected focal DiI into the nasal retina, which is targeted to a region located anteriorly from the posterior border of the wild-type SC. However, in EphA8-overexpressing mice, we reproducibly found that the TZ shifted more towards the caudal SC despite the similar nasal injection site. Unlike TZs found in EphA8-E10 expressing mice, TZs in EphA8-overexpressing mice were not separated into several regions consisting of major and minor TZs but were detected as only one prominent region. This result was described in the original manuscript although the data were not shown (see page 16, lines 7-10). We do not agree with the reviewer that the quantification of map disruption with ephrinA5-GFP BAC mice is small and not convincing. Because these focal DiI tracing data may result from a slight difference in DiI injection sites in the nasal retina, we had to use ephrinA5-GFP to quantify the map disruptions in EphA8-overexpressing mice as shown in Fig. 5 . We believe that these data based on GFP-labeled termination domains are more technically convincing than the focal DiI tracing method.
Point 9a.
The reviewer commented on the number of axons in the co-culture experiment. It was not easy to quantify the number of axons growing out of the explant. Many of the EGFP-labeled nasal RGC axons are very thin and could be clearly seen only under higher magnification. Therefore, using Adobe Photoshop, axon images taken under higher magnification were connected to record the detailed image of the entire axonal outgrowth field. These methods were used for quantification when the EGFP-labeled axons on the cell aggregate were compared with the total number of axons growing out of the explant (see the legend for Fig. 6A ).
Point 9b.
As the reviewer suggested, the nasal RGC explant is much closer to the cell clump expressing EphA8-E10 than that expressing wild-type EphA8. The reviewer was concerned whether this may affect our interpretation regarding the magnitude of the attraction of nasal RGC axons to the EphA8-E10 mutant. As we explained in the manuscript, similar-sized, small cell clumps were collected from 293 cultures expressing either EphA8 or EphA8-E10, and each cell clump was placed on either side of strips of the mouse nasal retina. A few hours after co-culture onset, we re-examined whether each cell clump looked similar in size and was equally distant from the explant. These were important criteria for our co-culture experiments. If the status of each cell clump did not meet our standards, 2 days of co-culture were not continued. When the nasal RGC explant and cell clumps satisfied our criteria, they were allowed to grow for 2 additional days. We always found that the cell clump with EphA8-E10 became much closer to the explant, possibly due to adhesive interactions between the cell clump and the ingrowing axons. During 2 days of culture, most axons growing out of the explant were long enough to extend past the cell clump. Some of the axons remained short, and most of those did not contain a large growth cone under higher magnification, suggesting that those axonal tips had retracted or collapsed upon encountering a repulsive cue such as EphA receptors. Based on many experiments, we believe that 2 days of coculture is sufficient time to allow the nasal RGC axons to contact the cell clump expressing EphA or EphA8-E10 (see supplementary materials, page 9, lines 9-19; page 10, lines 1-4).
Point 9c.
The reviewer also asked why the axons grow so much into the cell clump if there is adhesion. One possible explanation is that upon Eph/ephrin interaction, the growing axons stop due to a strong adhesive interaction and then begin moving again due to turnover of EphA-ephrinA complexes. Because this adhesive interaction is a dynamic process, we predict that axons keep navigating along the adhesive substrate.
Point 9d.
The reviewer suggested an interesting experiment using soluble ephrinA5-Fc to block the adhesive interaction between the cell clump and nasal RGC axons. However, these experiments were not successful because addition of ephrinA5-Fc to the nasal RGC explant culture resulted in inhibition of axonal outgrowth from the nasal RGC explant. After 2 days of culture, the explant was floating and underwent apoptotic cell death. Please note that Depaepe et al. (Nature; 2005) reported that Eph/ephrin signaling is a physiological trigger for apoptosis, thereby regulating the number of neural progenitors.
Point 10.
The reviewer asked why the magnitude of the phenotype was variable between the two transgenic BAC lines. We believe that the reason for the variation is likely due to the BAC copy number inserted into the genome of each mouse line. Based on semi-quantitative PCR analysis with genomic DNAs isolated from different transgenic lines, we estimated that recombinant BACs are incorporated into the mouse genome within a range of 1-4 copies (page 27, lines 17-19; page 28, line 1).
Point 11.
We agree with the reviewer that our model had some flaws. In our new model, contact of EphA-expressing cells with ephrinA-expressing axons induces the ephrinA-p75 NTR complex to mediate reverse signaling for axon repulsion but also induces the EphA-RacGEF complex to modulate Rac activity and actin polymerization, which are possible critical events for Eph-ephrin endocytosis. EphA-ephrinA endocytotic processes cause destabilization of cell-cell contacts and initiate cell-cell detachment. Without involvement of these endocytotic processes, ephrin-A reverse signaling would not effectively lead to retraction of the nasal RGC axons away from anterior SC cells despite its potential repellent activity. One possible function of the exon10-encoded peptide region in EphA8 is to form a binding site for Rac-GEF that is critical for Eph-ephrin endocytosis. The EphA8-E10 mutant lacking this peptide region is defective in activating Rac signaling when it is bound to ephrin-As. Importantly, the EphA8-E10 mutant protein associates with other EphA receptors in the anterior SC. Therefore, after cell-cell contact, ephrinA-EphA complexes are not efficiently internalized into EphA8-E10-expressing cells. These enhanced adhesive events seem to override the repellent ephrin-A reverse signal triggered by the ephrinA-p75 NTR complex, resulting in abnormal development of the retinocollicular topography (page 30, lines 1-19; supplementary figure 4).
Point 12.
As the reviewer suggested, we eliminated some interpretations of data from the revised Results section (pages 8-20).
Response to reviewer #3

Point 1a.
According to the reviewer's comment, Figs. 1B, 1D, and 1E are cited in the revised Results section (page 8, lines 16 and 18; page 9, lines 6, 14, 16 and 18).
Point 1b.
The reviewer suggested that we should more clearly describe the value we measured in the endocytosis assay. After cells were imaged with a confocal microscope, the fluorescent intensity of each cell was measured and adjusted for local background with NIH ImageJ software. Then, a mean fluorescent intensity per cell was calculated using 30-50 cells for each experiment (see supplementary materials, page 4, lines 14-17).
Point 1c.
We agree with the reviewer that "Relative binding of ephrinA5-Fc" is not appropriate as a y-axis label. We have modified the y axis to "Mean fluorescent intensity" (see Fig. 1B and D, Fig.  3E and H, Fig. 7D, supplementary Fig. 3D, and Fig. 8G ).
Point 2.
As the reviewer suggested, HA has been labeled on the EphA8 and EphA8-E10 constructs to more clearly mark the HA-tagged protein (see Fig. 1E ).
Point 3.
As the reviewer suggested, SC borders have now been marked with dotted lines for the brains in supplementary Fig. 1B , and the image has been adjusted for publication quality (see supplementary Fig. 1B) .
Point 4.
We have now corrected "wild type (left) ...transgenic mice (right)" to "wild type (top)… transgenic mice (bottom)" (see supplementary materials, page 12, lines 14-15).
Point 5.
We have now inserted an N value for the explant number in Fig. 6 (page 48, line 10).
Point 6a.
We have now corrected 
Point 6b.
As the reviewer suggested, we have added a bracket to indicate the comparison that is statistically significant in supplementary Fig. 3D .
Point 6c.
We agree with the reviewer that the close-up of panel b in supplementary Fig. 3F is not informative of whether axons avoided the explant. As the reviewer suggested, we now show a close-up of a region where axons are present within the cell clump (see supplementary Fig. 3F , bottom panel).
Point 7.
The reviewer asked us to describe criteria for performing the experiments presented in the explant culture. This question is very similar to the comment raised by reviewer #2 in Point 9b. Please see the details and justifications of the criteria for the ex vivo experiments that we have addressed in response to Point 9b of reviewer #2 (see supplementary materials, page 9, lines 9-19; page 10, lines 1-4).
Point 8.
We have now inserted an N value for the SC number in Fig. 8J and K (page 51, line 3).
Point 9.
The reviewer commented about the terminology regarding "attraction vs. adhesion". We agree with the reviewer that "adhesion" should be used in place of "attraction". We have made this correction in the revised text (page 21, line 12; page 24, line 8; page 29, line 18).
Point 10.
We agree with the reviewer that some statements were not clearly and precisely presented in the Discussion section. Please see the modified statements in the revised manuscript (page 28, lines 17-19; page 29, lines 1-5).
Point 11a.
The reviewer asked why the anterior shift in mapping in the SC was manifested (much) more medially than laterally. This result was expected because EphA receptors were more strongly expressed in a region close to the midline of the SC (see supplementary Figs. 1 and 2 ). In the medial region, the magnitude of the diminished repellent activity was greater because those SC cells are more strongly affected by high levels of EphA8-E10 (page 27, lines 9-14).
Point 11b.
As the reviewer suggested, we have added more appropriate explanations regarding the in vitro stripe assay reported by Rashid et al. and Lim et al (page 28, .
Point 11c and 12.
All the reviewers had similar comments and questions on our model of how ephrin-A that is trans-endocytosed into EphA-expressing SC cells regulates the repellent activity of nasal RGC axons. Therefore, we have modified our previous model to accommodate all the referees' comments, previous reports (Rashid et al., Lim et al.) , and our current findings. In our new model, we have eliminated the statement "we propose that the removal and trans-endocytosis of ephrin-As from nasal RGC axons may strengthen the activation of their co-receptors such as p75 NTR " because this hypothesis is too controversial. A key point in our modified model is that contact of EphAexpressing cells with ephrinA-expressing axons induces an ephrinA-p75 NTR complex to mediate reverse signaing for axon repulsion but also induces the EphA-RacGEF complex to modulate Rac activity for Eph-ephrin endocytosis. The balance between adhesion and repulsion depends on how rapidly EphA-ephrinA endocytosis causes destabilization of cell-cell contact and initiates cell-cell detachment. If endocytosis was defective, the adhesive signal would predominate over the repellent signal of the ephrinA-p75NTR complex. We hope that our new model illustrated in the legend for Thank you for submitting your revised manuscript to the EMBO Journal. I asked the original referee #2 to review the revised version and I have now received the comments back. As you can see, the referees appreciate that the revised manuscript has addressed many of the original raised concerns. The referee still has some outstanding concerns regarding the proposed model. The referee suggests some additional experiments to further test the proposed model. I have consulted further with referee #2 regarding the suggested experiments and we both have come to the conclusion that they are not necessary. Given this I am therefore pleased to proceed with acceptance of the paper for publication here. Before doing so I have a few minor suggestions. 1) Most of the materials and method is in the supplemental data. Let us move that into the main manuscript. I know that the character count will go above the 55000, but that is OK. 2) I think it would be a good idea to move the model figure from the supplemental file into the main article -it just makes it easier to find. You can use the link below to upload the revised manuscript -please note that no more experiments are needed. Once we receive the revised version, we will accept it for publication here.
Thank you for submitting your interesting study to the EMBO Journal Yours sincerely,
Editor
The EMBO Journal
REFEREE REPORTS
The new version of the manuscript from the Park lab on EphA endocytosis and retinotectal mapping has addressed properly a number of points indicated in my comments and that of the other reviewers.
Similar to the other referees, I found the data presented unexpected, and no convincing model was presented to explain their data. I think even the new version of their model is not convincing and the danger is that their in vivo data could be also explained not by endocytosis but by some other mechanism/s.
Normally, activation of an ephrinA/p75 complex on RGC axons by EphAs expressed on tectal cells results in a repellent response. One might expect here possibly endocytosis of the ephrinA/p75 complex into the RGC axons to terminate the signal or ongoing signalling from an endosome.
However, the authors propose that trans-endocytosis of ephrinAs from RGC axons into tectal cells is necessary -according to their data/figures/model -to trigger an (increased) repellent response, possibly because the p75 receptor devoid of ephrinAs signals stronger (Suppl Fig 4) . They report that if EphA endocytosis is blocked in tectal cells by expression of an endocytosis-deficient form of EphA8, the repulsion is abolished. The concept is apparently supported by data using the expression of rac in tectal cells.
I would like to see data that in vivo after overexpression of a dominant-neg form of rac the protein expression pattern of EphA receptors in gradients is the same as in the wild type situation. One explanation of the phenotype the authors observe here might be that because of the inactivation of rac, the surface expression of EphA receptors is affected and results in a weaker gradient inducing ectopic termination zones in the anterior tectum, that is the cause of the phenotype is not endocytosis but lack of transport of the EphA receptors to the surface. Possibly the same is true for expression of the endocytosis-deficient EphA8 receptor which might cause a reduction of EphA receptor transport to the surface.
